Pirayeh Eftekhari

Paris, 75010, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma.

Progressive erythrocytosis under lenvatinib treatment in patients with advanced hepatocellular carcinoma.

Journal: Cancer chemotherapy and pharmacology

Published: December 02, 2022

Agreement between a regional pharmacovigilance centre and an adjudication committee regarding adverse drug reactions on a cohort of hospitalised children.

Agreement between a regional pharmacovigilance centre and an adjudication committee regarding adverse drug reactions on a cohort of hospitalised children.

Journal: Therapie

Published: October 29, 2021

Characteristics of insulinopenic and non insulinopenic diabetes related to immune checkpoint inhibitors: A French pharmacovigilance study.

Characteristics of insulinopenic and non insulinopenic diabetes related to immune checkpoint inhibitors: A French pharmacovigilance study.

Journal: Therapie

Published: January 21, 2021

Drug-induced eosinophilic fasciitis: A dual pharmacovigilance analysis.

Drug-induced eosinophilic fasciitis: A dual pharmacovigilance analysis.

Journal: Journal of the American Academy of Dermatology

Published: December 05, 2020

Highlights on the risk of pulmonary tuberculosis in patients on ibrutinib treatment: Case report and literature review.

Highlights on the risk of pulmonary tuberculosis in patients on ibrutinib treatment: Case report and literature review.

Journal: EJHaem

Published: June 15, 2020

Severe immune-related hepatitis induced by immune checkpoint inhibitors: Clinical features and management proposal.

Severe immune-related hepatitis induced by immune checkpoint inhibitors: Clinical features and management proposal.

Journal: Clinics and research in hepatology and gastroenterology

Published: April 25, 2020

Severe gastrointestinal toxicity of MEK inhibitors.

Severe gastrointestinal toxicity of MEK inhibitors.

Journal: Melanoma research

Published: May 17, 2019

Osteopenia and fractures associated with long-term therapy with MEK inhibitors.

Osteopenia and fractures associated with long-term therapy with MEK inhibitors.

Journal: Melanoma research

Published: August 21, 2018

Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study.

Occurrence of type 1 and type 2 diabetes in patients treated with immunotherapy (anti-PD-1 and/or anti-CTLA-4) for metastatic melanoma: a retrospective study.

Journal: Cancer immunology, immunotherapy : CII

Published: October 03, 2017

Erratum to: Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers.

Erratum to: Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers.

Journal: Archives of gynecology and obstetrics

Published: March 04, 2017

Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers.

Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers.

Journal: Archives of gynecology and obstetrics

Published: November 22, 2016

Quetiapine and anticholinergic drugs induced ischaemic colitis: A case study

Quetiapine and anticholinergic drugs induced ischaemic colitis: A case study

Journal: L'Encephale

Published: October 16, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026